학술논문
Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial
Document Type
Article
Author
Source
In: Trials . (Trials, December 2024, 25(1))
Subject
Language
English
ISSN
17456215